Barclays upgraded shares of Sonova (OTCMKTS:SONVY – Free Report) from a strong sell rating to a strong-buy rating in a research report report published on Tuesday morning,Zacks reports.
Other analysts also recently issued research reports about the stock. UBS Group downgraded shares of Sonova from a “strong-buy” rating to a “hold” rating in a report on Monday, November 2nd. Citigroup reaffirmed a “sell” rating on shares of Sonova in a report on Friday, July 24th. Royal Bank Of Canada downgraded shares of Sonova from a “moderate buy” rating to a “hold” rating in a research report on Friday, November 6th. Jefferies Financial Group upgraded shares of Sonova from a “moderate sell” rating to a “hold” rating in a research report on Monday, November 9th. Finally, The Goldman Sachs Group upgraded Sonova from a “hold” rating to a “buy” rating in a research note on Thursday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold”.
Get Our Latest Stock Analysis on SONVY
Sonova Price Performance
SONVY stock opened at $68.89 on Tuesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.43 and a current ratio of 1.75. The company’s 50-day simple moving average is $63.91 and its 200 day simple moving average is $54.08. Sonova has a 52 week low of $42.26 and a 52 week high of $71.91.
Sonova Company Profile
Sonova is a Switzerland-based hearing care company headquartered in Stäfa. Founded in 1947 as AG für Elektroakustik, it has grown into a global provider of products and services for people with hearing loss. The company develops and sells hearing aids under brands including Phonak and Unitron, as well as cochlear implant systems through Advanced Bionics. Its offerings also include wireless hearing solutions and consumer audio products sold under the Sennheiser brand. Sonova serves customers worldwide through product sales and audiological care services, including hearing assessments, fittings and ongoing support.
Featured Articles
- Five stocks we like better than Sonova
- Target Stock Is Up Over 70%—Has the Easy Money Already Been Made?
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.
